31.12.2024 | Statement of Deviation/Variation for Quarter ended 31st December, 2024 |  |
31.12.2024 | Details of KMP for Determining Materiality of Events |  |
31.12.2024 | Monitoring Agency Report 31st December, 2024 |  |
28.12.2024 | Trading Window Closure December 2024 |  |
22.11.2024 | Update under Regulation 30 |  |
01.11.2024 | Update on Subsidiary Company 01.11.2024 |  |
30.09.2024 | Monitoring Agency Report 30.09.2024 |  |
05.8.2024 | Update on our intimation dated 05th August, 2024 |  |
01.10.2024 | Announcement_ EDQM certification to supply Ibuprofen in Europe |  |
28.09.2024 | Trading Window Closure September 2024 |  |
29.08.2024 | Communication to Shareholders holding shares in physical mode for furnishing of their KYC details. |  |
05.08.2024 | Announcement under 30 Change in directors |  |
30.06.2024 | Monitoring Agency Report 30.06.2024 |  |
30.06.2024 | Statement of Deviation/Variation for Quarter ended 30th June, 2024 |  |
28.06.2024 | Trading Window Closure June 2024 |  |
29.05.2024 | Related Party Transaction 29.05.2024 |  |
14.05.2024 | Monitoring Agency Report March 2024 |  |
31.03.2024 | Annual Secretarial Compliance Report for the FY 2023-24 |  |
31.03.2024 | Statement of Deviation/Variation for Quarter ended 31st March, 2024 |  |